These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38361107)

  • 1. Review: Are moles senescent?
    Bennett DC
    Pigment Cell Melanoma Res; 2024 May; 37(3):391-402. PubMed ID: 38361107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes.
    Ruiz-Vega R; Chen CF; Razzak E; Vasudeva P; Krasieva TB; Shiu J; Caldwell MG; Yan H; Lowengrub J; Ganesan AK; Lander AD
    Elife; 2020 Oct; 9():. PubMed ID: 33047672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanocytic Nevi and the Genetic and Epigenetic Control of Oncogene-Induced Senescence.
    Huang JM; Chikeka I; Hornyak TJ
    Dermatol Clin; 2017 Jan; 35(1):85-93. PubMed ID: 27890240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.
    Fan T; Jiang S; Chung N; Alikhan A; Ni C; Lee CC; Hornyak TJ
    Mol Cancer Res; 2011 Apr; 9(4):418-29. PubMed ID: 21383005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression.
    Soo JK; Mackenzie Ross AD; Kallenberg DM; Milagre C; Heung Chong W; Chow J; Hill L; Hoare S; Collinson RS; Hossain M; Keith WN; Marais R; Bennett DC
    Pigment Cell Melanoma Res; 2011 Jun; 24(3):490-503. PubMed ID: 21418545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocytic nevi and melanoma: unraveling a complex relationship.
    Damsky WE; Bosenberg M
    Oncogene; 2017 Oct; 36(42):5771-5792. PubMed ID: 28604751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescence-Like Phenotypes in Human Nevi.
    Joselow A; Lynn D; Terzian T; Box NF
    Methods Mol Biol; 2017; 1534():175-184. PubMed ID: 27812879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human nevi: no longer precursors of melanomas?
    Zhang G; Herlyn M
    J Invest Dermatol; 2012 Sep; 132(9):2133-4. PubMed ID: 22895446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of melanocytic nevi.
    Roh MR; Eliades P; Gupta S; Tsao H
    Pigment Cell Melanoma Res; 2015 Nov; 28(6):661-72. PubMed ID: 26300491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of distinguishing senescence traits in human melanocytic nevi.
    Tran SL; Haferkamp S; Scurr LL; Gowrishankar K; Becker TM; Desilva C; Thompson JF; Scolyer RA; Kefford RF; Rizos H
    J Invest Dermatol; 2012 Sep; 132(9):2226-34. PubMed ID: 22513787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A murine model for the development of melanocytic nevi and their progression to melanoma.
    Nasti TH; Cochran JB; Tsuruta Y; Yusuf N; McKay KM; Athar M; Timares L; Elmets CA
    Mol Carcinog; 2016 May; 55(5):646-58. PubMed ID: 25788145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanocytic nevi and tumor progression: perspectives concerning histomorphology, melanoma risk and molecular genetics.
    Barnhill RL
    Dermatology; 1993; 187(2):86-90. PubMed ID: 8358111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression.
    Kohli J; Ge C; Fitsiou E; Doepner M; Brandenburg SM; Faller WJ; Ridky TW; Demaria M
    Nat Commun; 2022 Dec; 13(1):7923. PubMed ID: 36564381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of clonality in melanocytic nevi.
    Hui P; Perkins A; Glusac E
    J Cutan Pathol; 2001 Mar; 28(3):140-4. PubMed ID: 11168766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and evolving concepts of melanocytic nevi and melanocytomas.
    Yeh I
    Mod Pathol; 2020 Jan; 33(Suppl 1):1-14. PubMed ID: 31659277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer.
    Bastian BC
    Oncogene; 2003 May; 22(20):3081-6. PubMed ID: 12789284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Genomic Profiling of Melanocytic Nevi.
    Colebatch AJ; Ferguson P; Newell F; Kazakoff SH; Witkowski T; Dobrovic A; Johansson PA; Saw RPM; Stretch JR; McArthur GA; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Waddell N; Scolyer RA; Wilmott JS
    J Invest Dermatol; 2019 Aug; 139(8):1762-1768. PubMed ID: 30772300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas.
    Richmond A; Fine R; Murray D; Lawson DH; Priest JH
    J Invest Dermatol; 1986 Mar; 86(3):295-302. PubMed ID: 3745955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs.
    Zhu G; Duffy DL; Eldridge A; Grace M; Mayne C; O'Gorman L; Aitken JF; Neale MC; Hayward NK; Green AC; Martin NG
    Am J Hum Genet; 1999 Aug; 65(2):483-92. PubMed ID: 10417291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
    Vredeveld LC; Possik PA; Smit MA; Meissl K; Michaloglou C; Horlings HM; Ajouaou A; Kortman PC; Dankort D; McMahon M; Mooi WJ; Peeper DS
    Genes Dev; 2012 May; 26(10):1055-69. PubMed ID: 22549727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.